Answer
Lutetium (177Lu) oxodotreotide has high affinity for subtype 2 somatostatin receptors (SSTR2) and binds to malignant cells that overexpress SSTR2.
Sources for this answer
- Lutathera 370 MBq/mL solution for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 8Document updated
Sources checked